Loading...

FITC anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1dot4_FITC_011409.jpg
C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
  • HK1dot4_FITC_011409.jpg
    C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
Compare all formats See FITC spectral data
Cat # Size Price Save
128005 50 µg ¥19,580
128006 500 µg ¥64,460
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  2. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  3. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  4. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  5. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  6. Duan Y, et al. 2019. Circ Res. 125:969. PubMed
  7. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  8. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  9. Zaman R, et al. 2021. Immunity. :. PubMed
  10. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  11. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
  12. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  13. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  14. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  15. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  16. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  17. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  18. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  19. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  20. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  21. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  22. You Y, et al. 2016. Sci Rep. 6:20630. PubMed
  23. Dong L, et al. 2021. Cancer Cell. . PubMed
  24. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  25. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  26. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  27. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  28. Chen JS, et al. 2022. Sci Immunol. 7:eabl5652. PubMed
  29. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  30. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  31. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  32. McAlpine CS, et al. 2019. Nature. 566:383. PubMed
  33. Buzas K, et al. 2011. Cytokine. 55:429. PubMed
  34. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  35. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  36. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  37. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  38. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  39. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  40. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  41. Al-Sharea A, et al. 2017. Cell Cycle. 10.1016/j.atherosclerosis.2017.08.010. PubMed
  42. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  43. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  44. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  45. Mirakaj V, et al. 2014. J Exp Med. 211:1037. PubMed
  46. Park Y, et al. 2013. Cancer Res . 73:5669. PubMed
  47. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  48. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  49. Naler LB, et al. 2022. Commun Biol. 5:102. PubMed
  50. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  51. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  52. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  53. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  54. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  55. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  56. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  57. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  58. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  59. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  60. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  61. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  62. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  63. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  64. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  65. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  66. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  67. Cao Y, et al. 2015. J Biol Chem. 290: 23050-23063. PubMed
  68. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  69. Körner A,et al. 2017. Cell Death Differ.. 10.1038/cdd.2017.177. PubMed
  70. He J, et al. 2019. J Clin Invest. 130. PubMed
  71. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  72. Xu Y, et al. 2016. Arthritis Rheum. 67: 225-237. PubMed
  73. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  74. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  75. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  76. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  77. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
  78. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  79. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  80. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  81. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  82. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  83. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  84. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  85. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  86. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  87. Lee S, et al. 2011. J Immunol. 186:6972. PubMed
  88. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  89. Zhao T, et al. 2022. JCI Insight. 7:. PubMed
  90. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  91. Alvarez-Breckenridge C, et al. 2012. J Virol. 86:4566. PubMed
  92. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  93. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  94. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  95. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  96. Moore J, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 906-917. PubMed
  97. León-Cabrera S, et al. 2014. Int J Biol Sci. 9 948 . PubMed
  98. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  99. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  100. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  101. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  102. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  103. Kwak T, et al. 2020. Cell Reports. 33(13):108571. PubMed
  104. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  105. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  106. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  107. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  108. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  109. Tyagi A, et al. 2021. Nat Commun. 12:474. PubMed
  110. Tang S, et al. 2022. Virol J. 19:32. PubMed
  111. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  112. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  113. Caballero S, et al. 2017. Invest Ophthalmol Vis Sci. 58:5164. PubMed
  114. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  115. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  116. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  117. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  118. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  119. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  120. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  121. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  122. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  123. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  124. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  125. Rahtes A, et al. 2020. Front Immunol. 1.484722222. PubMed
  126. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  127. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  128. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  129. Jones GS, et al. 2020. mSphere. 5:. PubMed
  130. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  131. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  132. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  133. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  134. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  135. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  136. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  137. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  138. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  139. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
  140. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
RRID
AB_1186134 (BioLegend Cat. No. 128005)
AB_1186135 (BioLegend Cat. No. 128006)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org
Go To Top Version: 2    Revision Date: 12/09/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account